The Surveillance, Evidence and Laboratory Strengthening Unit (SEL) provides countries with guidance and tools to enhance bacteriology and mycology diagnostic, epidemiology, and IT capacities. The aim is to inform the development and implementation of policies and practices to reduce the burden of antimicrobial resistance by providing equitable access to high-quality testing, prioritizing patient management and generating essential quality data through surveillance and research. The SEL unit leads the following initiatives:

• Global Antimicrobial Resistance and Use Surveillance System (GLASS)
  Provides a standardized approach for countries to collect, analyze, interpret, and share AMR data, aiming to support capacity building and to monitor the status of existing and new national surveillance systems.
• Antimicrobial Resistance Diagnostic Initiative
  Aims to strengthen bacteriology and mycology diagnostics capacity, laboratory systems, and service delivery, particularly in low-resource settings.
• Evidence generation, Research, and Innovation
  Support the utilization of surveillance data to inform policy and clinical care; assist Member States and partners in identifying research priorities and addressing knowledge gaps using the Global AMR research agenda in human health; and promoting digital health solutions.